Benitec Biopharma Stock Price - BNTC

7.00
-0.01 (-0.14%)
Upgrade to Real-Time
Afterhours (Closed)
7.01
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Benitec Biopharma Limited BNTC NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.355 5.33% 7.01 6.7579 7.20 6.90 6.655 17:57:05
Bid Price Ask Price Spread Spread % News
7.01 8.80 1.79 20.34% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
88 9,698 $ 7.03 $ 68,150 25,926 0.50 - 17.3894
Last Trade Time Type Quantity Stock Price Currency
16:00:00 6 $ 7.00 USD

Benitec Biopharma Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 2.25B 321.29M 321.29M $ 11.35M $ - 0.01 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Benitec Biopharma News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical BNTC Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week6.997.766.65137.2213,3250.020.29%
1 Month8.199.336.537.9322,730-1.18-14.41%
3 Months3.4817.38942.7611.6772,4263.53101.44%
6 Months5.5017.38942.768.8173,6851.5127.45%
1 Year1.6217.38940.505.6563,1265.39332.72%
3 Years2.4717.38940.504.2443,4074.54183.81%
5 Years12.1217.38940.503.7181,084-5.11-42.16%

Benitec Biopharma Description

Benitec Biopharma Inc is a biotechnology company developing a proprietary therapeutic technology platform that combines RNA interference with gene therapy for providing sustained, long-lasting silencing of disease-causing genes from a single administration. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The company is developing product candidates in chronic and life-threatening human disease areas including Orphan disease: Oculopharyngeal Muscular Dystrophy (OPMD) and Infectious disease: Hepatitis B Virus (HBV).


Your Recent History
NASDAQ
BNTC
Benitec Bi..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.